AmerisourceBergen agrees to acquire PharmaLex for $1.29bn
Pharmaceutical Technology
SEPTEMBER 13, 2022
The acquisition will expand the international solutions portfolio of AmerisourceBergen aiding in advancing its position as a preferred partner for biopharmaceutical manufacturers. On closing of the deal, the results of PharmaLex will be included as a component within the International Healthcare Solutions sector of AmerisourceBergen.
Let's personalize your content